Moody’s downgrades Senegal to Caa1 amid rising debt concerns
Investing.com - InflaRx reported on Wednesday third quarter earnings that beat analysts' forecasts and revenue that was inline with expectations.
InflaRx announced earnings per share of €-0.180 on revenue of €0.00. Analysts polled by Investing.com EPS of €-0.325 on revenue of €0.00.
InflaRx 's are down 28.9% and is trading at €2.660 , still down 53.22% from its 52 week high of €5.69 set on Monday, November 15, 2021.
InflaRx shares lost 2.56% to trade at €2.660 in intra-day trade the report.
InflaRx follows other major Healthcare sector earnings this month
InflaRx's report follows an earnings beat by UnitedHealth on Friday, October 14, 2022, who reported EPS of €5.79 on revenue of €80.89B, EPS of €5.43 on revenue of €80.52B.
J&J had beat expectations on Tuesday, October 18, 2022 with third quarter EPS of €2.55 on revenue of €23.79B, for EPS of €2.52 on revenue of €23.46B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar